课题基金 / 基金详情

Chemoprotective effects of natural products on colonic adult stem cells

Chemoprotective effects of natural products on colonic adult stem cells
天然产物对结肠成体干细胞的化学保护作用
批准号:
8704733
负责人:
Robert Stephen Chapkin
金额:
$28.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-08 至 2016-07-31

项目摘要

项目成果

Robert Stephen Chapkin的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们已经证明,含有姜黄素(姜黄素)和柑橘(柠檬素)生物活性的化学保护性饮食可以降低慢性炎症和结肠癌风险。在癌症生物学方面,最近的观察表明,隐窝干细胞是肠癌的起源细胞。由于非编码microRNA介导的翻译抑制和染色质结构的改变可能与结肠癌的发生有关,因此确定化学预防饮食对microRNA及其信使RNA(MRNA)靶标的影响,以及表观遗传修饰对肠道干细胞中组蛋白和DNA水平的影响是至关重要的。然而,到目前为止,膳食植物性药物对肠道干细胞、隐窝和肿瘤中全基因组染色质表观遗传修饰、microRNAs和mRNAs群体的影响尚未确定。因此,我们假设,含有姜黄素和/或柑橘生物活性柠檬素的化学保护性饮食将调节干细胞转录组,导致疾病进展的有利转变。目的1利用高度特异的干细胞特异性Lgr5-LacZ和LGR-EGFP小鼠,定量研究在含有姜黄素、柠檬及其混合物的饮食中,在结肠癌发生的起始阶段和肿瘤阶段,干细胞的数量和时空位置、DNA损伤和结肠癌隐窝中的靶向凋亡。目的2将利用Lgr5-EGFP小鼠研究疾病进展对结肠干细胞、完整的结肠隐窝和暴露于致癌物/炎症或生理盐水(对照)后的肿瘤中microRNAs及其转录后调控的mRNA靶标的影响。AIM 3将使用染色质免疫沉淀为(I)肠上皮细胞隐窝和(Ii)结肠肿瘤生成高分辨率全基因组“染色质状态”图谱,以评估饮食和结肠炎相关的结肠癌发生对组蛋白和DNA水平的表观遗传修饰的影响。预计从这些研究中将出现新的干细胞信号网络和标记物。拟议的研究将促进我们理解植物药物如何影响正常肠道发育和恶变过程中的关键信号通路,包括干细胞的自我更新。
英文摘要
DESCRIPTION (provided by applicant): We have demonstrated that chemoprotective diets containing turmeric (curcumin) and citrus (limonin) bioactives reduce chronic inflammation and colon cancer risk. With respect to cancer biology, recent observations demonstrate that crypt stem cells are the cells-of-origin of intestinal cancer. Since non-coding microRNA-mediated translational repression and changes to chromatin structure may be linked to the development of colon cancer, it is vital that the effect of chemopreventive diets on microRNAs, their messenger RNA (mRNA) targets, and epigenetic modifications on both the histone and DNA levels in intestinal stem cells be determined. However, to date, the effect of dietary botanicals on genome-wide chromatin epigenetic modifications, microRNAs, and mRNA populations in intestinal stem cells, crypts and tumors has not been determined. Therefore, we hypothesize that a chemoprotective diet, containing curcumin and/or the citrus bioactive limonin, will modulate the stem cell transcriptome, resulting in a favorable shift in disease progression. Aim 1 will use highly novel stem cell specific Lgr5-LacZ and Lgr-EGFP mice to quantify the number and spatio-temporal location of stem cells, DNA damage and targeted apoptosis in the colonic crypt at the initiation and tumor stages of colon carcinogenesis following exposure to diets containing curcumin, limonin, and their mixture. Aim 2 will use the Lgr5-EGFP mouse to investigate the effect of disease progression on microRNAs and their post-transcriptionally regulated mRNA targets in colonic stem cells, intact colonic crypts and tumors following carcinogen/inflammation or saline (control) exposure. Aim 3 will generate high-resolution genome- wide "chromatin-state" maps for (i) intestinal epithelial cell crypts, and (ii) colonic tumors using chromatin immunoprecipitation in order to assess the effect of diet and colitis-associated colon carcinogenesis on epigenetic modifications at both the histone and DNA levels. It is anticipated that novel stem cell signaling networks and markers will emerge from these studies. The proposed studies will promote our understanding of how botanicals impact critical signaling pathways during normal intestinal development and malignant transformation, including self-renewal of stem cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
  • 批准号:
    10047029
  • 项目类别:
  • 资助金额:
    $57.92万
  • 财政年份:
    2020
  • 负责人:
    Robert Stephen Chapkin
  • 依托单位:
Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
  • 批准号:
    10401939
  • 项目类别:
  • 资助金额:
    $54.09万
  • 财政年份:
    2020
  • 负责人:
    Robert Stephen Chapkin
  • 依托单位:
Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans
  • 批准号:
    10603601
  • 项目类别:
  • 资助金额:
    $19.05万
  • 财政年份:
    2020
  • 负责人:
    Robert Stephen Chapkin
  • 依托单位:
海外基金